Allergy Immunotherapy Market By Treatment Type-
Allergy Immunotherapy Market By Allergy Type-
Allergy Immunotherapy Market By Distribution Channel-
Allergy Immunotherapy Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Allergy Immunotherapy Market Snapshot
Chapter 4. Global Allergy Immunotherapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Industry
Chapter 5. Market Segmentation 1: By Treatment Type Estimates & Trend Analysis
5.1. By Treatment Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Treatment Type:
5.2.1. Subcutaneous Immunotherapy (SCIT)
5.2.2. Sublingual Immunotherapy (SLIT)
5.2.2.1. Tablets
5.2.2.2. Drops
Chapter 6. Market Segmentation 2: By Allergy Type Estimates & Trend Analysis
6.1. By Treatment Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Allergy Type:
6.2.1. Allergic rhinitis
6.2.2. Allergic asthma
6.2.3. Others
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Treatment Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy
7.2.3. Online Pharmacy
Chapter 8. Allergy Immunotherapy Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Treatment Type, 2021-2034
8.1.2. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.1.3. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.1.4. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.2.2. Europe Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.2.3. Europe Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.2.4. Europe Allergy Immunotherapy Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.3.2. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.3.3. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.3.4. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.4.2. Latin America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.4.3. Latin America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.4.4. Latin America Allergy Immunotherapy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, (US$ Million)
8.5.2. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.5.3. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.5.4. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ASIT Biotech
9.2.2. Circassia
9.2.3. Mylan N.V.
9.2.4. Adamis Pharmaceuticals Corporation
9.2.5. Merck KGaA
9.2.6. Stallergenes Greer plc
9.2.7. Allergy Therapeutics
9.2.8. ALK-Abelló A/S
9.2.9. DESENTUM OY
9.2.10. HAL Allergy B.V.
9.2.11. HollisterStier Allergy
9.2.12. LETIPharma
9.2.13. DBV Technologies SA
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.